Jingjing Zhang, Kun Wang, Yanyu Qiao, Mengjie Zhang, Yunqing Chen, Yulong Tian, Xuelong Jiao, Xiaojie Tan, Haitao Jiang, Feng Hou
Department of Pathology Department, Affiliated Hospital of Qingdao University, Qingdao, China.
Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao, China.
Front Immunol. 2025 Jun 12;16:1590219. doi: 10.3389/fimmu.2025.1590219. eCollection 2025.
PURPOSE: Colorectal cancer (CRC) is still one of the most common malignant tumors, with gradual increase in its annual morbidity and mortality. But most cases are diagnosed in the late stage. For stage II-III cancer, clinical guidelines recommend surgery following neoadjuvant radiation therapy at ≥6 weeks after the last radiotherapy is completed. However, radiotherapy may impair intestinal mucosal barrier function, especially the biological and immune barriers, accompanied by perioperative complications. This study was conducted to investigate the changes, repair patterns, and potential mechanisms in patients after radiotherapy. METHODS: This study detected inflammatory factors in postoperative intestinal mucosal tissue and serum, as well as metabolites in saliva samples, and collected hematoxylin-eosin (HE)-stained pathological images in CRC patients who had received and did not receive radiotherapy. RESULTS: The results showed that after radiotherapy, there were significantly impaired intestinal mucosal tissue structure; obviously elevated inflammatory factors in intestinal mucosal tissue and blood; as well as upregulation/downregulation of metabolites in saliva samples. CONCLUSION: In conclusion, findings in this study may provide potential reference for predicting the recovery of intestinal mucosa and selecting the optimal timing for surgery after radiotherapy. In addition, this study will benefit the understanding and reduction of perioperative complications caused by intestinal barrier damage.
目的:结直肠癌(CRC)仍是最常见的恶性肿瘤之一,其年发病率和死亡率呈逐渐上升趋势。但大多数病例在晚期才被诊断出来。对于II - III期癌症,临床指南建议在完成最后一次放疗后≥6周进行新辅助放疗后再进行手术。然而,放疗可能会损害肠道黏膜屏障功能,尤其是生物和免疫屏障,并伴有围手术期并发症。本研究旨在调查放疗后患者的变化、修复模式及潜在机制。 方法:本研究检测了术后肠道黏膜组织和血清中的炎症因子,以及唾液样本中的代谢物,并收集了接受和未接受放疗的CRC患者的苏木精-伊红(HE)染色病理图像。 结果:结果显示,放疗后肠道黏膜组织结构明显受损;肠道黏膜组织和血液中的炎症因子明显升高;唾液样本中的代谢物上调/下调。 结论:总之,本研究结果可为预测肠道黏膜恢复及选择放疗后手术的最佳时机提供潜在参考。此外,本研究将有助于理解和减少肠道屏障损伤引起的围手术期并发症。
Cochrane Database Syst Rev. 2020-10-19
Cochrane Database Syst Rev. 2022-9-26
Cochrane Database Syst Rev. 2018-2-6
Cochrane Database Syst Rev. 2022-5-20
Cochrane Database Syst Rev. 2017-7-31
Cochrane Database Syst Rev. 2018-7-9
Cochrane Database Syst Rev. 2021-4-19
Zhonghua Zhong Liu Za Zhi. 2024-3-23
Front Cell Infect Microbiol. 2023
Radiat Oncol J. 2023-6